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Abstract 
Malignant acanthosis nigricans is a cutaneous eruption characterized by symmetric 
hyperpigmented hyperkeratosis, dermal papillomatosis, and mucosal involvement 
associated with internal malignancies. Tripe palms refers to a characteristic velvety 
thickening of the palms, with exaggeration of normal skin markings. We present the 
second case of ovarian cancer in association with two coexisting paraneoplastic 
dermatoses occurring in a 57-year-old Korean female. The presence of acanthosis 
nigricans in conjunction with tripe palms in a female patient is highly suggestive of an 
internal malignancy including an ovarian cancer and demands an extensive search for 
the hidden ovarian cancer. 
 
Introduction 
Malignant acanthosis nigricans (MAN) is a cutaneous marker of internal malignancies. 
MAN has been known to be associated with intra-abdominal malignancies, most 
commonly gastric adenocarcinomas, along with tripe palms and the sign of Leser-Trélat. 
Unlike MAN associated with intra-abdominal malignancies, merely a few cases with 
MAN associated with gynecological malignancies have been reported. We present a case 
of MAN that was a manifestation of a paraneoplastic dermatosis of an ovarian cancer. 
The presence of sudden-onset MAN in conjunction with tripe palms may hint at 
gynecologic malignancies including ovarian cancers and necessitates extensive search for 
gynecologic cancers.  
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Case Report 
A 57-year-old woman presented with progressive hyperpigmentation and hyperkeratosis of 12 
months’ duration spreading from her upper extremities to the whole body. At first, she noted scattered 
skin tags on both forearms and thickened palms and soles. Minute physical examination revealed 
hyperpigmented velvety plaques on her neck, axillae, and groins, inflamed folds and whitish 
hyperplastic vegetations on the buccal mucosa and tongue, as well as multiple flat-topped papules on 
both forearms and coarse-thickened palms and soles. She presented with a diffuse velvety thickening 
and prominent ridges of the palms and soles (fig. 1). Well-defined thickened brownish plaques in the 
axillary area were observed (fig. 2). She had no systemic symptoms such as general fatigue, weight loss 
or melena. The past medical and family history provided no significant information. A skin biopsy of 
the hyperkeratotic plaque on her palms showed marked hyperkeratosis and acanthosis in the epidermis 
(fig. 3). Histopathologic examination of the plaque in the axillae revealed hyperkeratosis, slightly 
irregular acanthosis and prominent dermal papillomatosis, which were compatible with the 
histopathologic findings of acanthosis nigricans (fig. 4). The patient was started on etretinate 20 mg 
daily for 2 weeks for symptomatic control, and she was referred to an oncologist for an extensive 
examination for an underlying malignancy. The laboratory findings including CBC, liver function test, 
urinary function test, thyroid function test and serum protein electrophoresis test were all within the 
normal range. The radiologic findings of the lung, heart and skeletal scintigraphy showed no evidence of 
malignancy. Colonoscopy and esophagogastroduodenoscopy did not reveal any evidence of 
gastrointestinal tract malignancy. AFP (α-fetoprotein), CEA (carcinoembryonic antigen), and CA 19-9 
(carbohydrate antigen 19-9) were all within normal ranges, but the level of CA 125 (132 U/ml; normal 
range <35 U/ml) was elevated. Computed tomography (CT) and ultrasound of the abdomen were 
promptly performed and they revealed a 13.6 cm sized cystic and solid mass in the uterus (fig. 5). There 
were multiple paraaortic and retroperitoneal lymph node enlargements (fig. 5). She was diagnosed as 
stage IIIc ovarian carcinoma. The patient underwent exploratory laparotomy, total abdominal 
hysterectomy, bilateral salpingo-oophorectomy and periaortic lymph node sampling. In pathological 
examination, the mass turned out to be a serous adenocarcinoma. The patient was started on 
combination chemotherapy with paclitaxel and carboplastin, and her skin lesions gradually resolved 
after the third cycle of chemotherapy. After completing the sixth cycle of chemotherapy, her malignancy 
was in remission and she remained well with no aggravation and recurrence of the cancer and skin 
lesions for 2 years, except for mild hyperkeratosis of her axillae. 
Discussion 
MAN is a cutaneous eruption characterized by symmetric hyperpigmented 
hyperkeratosis, dermal papillomatosis, and mucosal involvement [1]. The most 
commonly involved locations are the axillae, neck, external genitalia, groin, face, inner 
thighs, perianal area, and antecubital and popliteal fossa [1]. MAN often accompanies 
tripe palms characterized by velvety thickening of the palms and exaggeration of the 
palmar ridges. As supported by numerous cases in the literature, the progressive form of 
acanthosis nigricans has been considered as a paraneoplastic dermatosis of intra-
abdominal malignancies along with tripe palms [2, 3]. Various intra-abdominal 
malignancies such as gastric, esophageal, pancreatic, and hepatic duct and cyst 
adenocarcinomas have been associated with MAN [4]. In comparison to intra-abdominal 
malignancies, MAN in conjunction with extra-abdominal malignancies, especially 
gynecological malignancies, is relatively rare. Based on the literatures, 6 cases of 
endometrial carcinoma [5, 6], 1 case [4] of squamous cell carcinoma of the cervix, 3 cases 
of ovarian cancer [4, 7, 14], and 1 case of uterine cancer [4] have been reported to occur 
in conjunction with MAN. 
Among these, ovarian cancer is the most common cause of death resulting from a 
gynecological tumor. In the United States, an estimated 21,650 new cases and 15,520 
deaths were projected for the year 2008 [8]. Ovarian cancer accounts for about 3% of all 
cancers among women and is the second most common gynecologic malignancy, next to 
endometrial carcinoma. Since clinical symptoms at early stages are rare and are often  
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mistaken for menopausal ailments or intestinal illnesses, the diagnosis is often made at 
advanced tumor stages with an overall 5-year survival rate of about 28% [9]. However, 
survival rates of greater than 80% have been reported with early-stage cancers, thus 
stimulating efforts to determine the role of population screening for the detection of early 
disease [10]. The survival rate of all patients with invasive epithelial ovarian cancer on 
screening (in the Shaaban and Rezvani group) was 89.9% at 2 years and 77.2% at 5 years, 
which was significantly higher than the survival rate of patients with ovarian cancer in the 
control group who did not have screening (2-year survival rate, 70.9%; 5-year survival 
rate, 48.7%) [10]. 
Therefore, identifying paraneoplastic dermatoses of ovarian cancer and detecting them 
earlier may play a role in screening procedures such as bimanual examination, 
ultrasonography, and measurement of serum tumor markers. Besides acanthosis 
nigricans, the paraneoplastic manifestations of ovarian cancer include paraneoplastic 
pemphigus, acquired ichthyosis, lupus-like syndrome, scleroderma and erythema 
annulare, digital necrosis, edema, and dermatographism [8]. In addition to the above 
mentioned dermatoses, recognition of the features and existence of a prodrome of ovarian 
carcinoma is important, since prodromal symptoms may manifest in conjunction with 
paraneoplastic skin changes. In general, a third to half of the patients developing ovarian 
cancer note recurrent abdominal bloating and pain, urinary symptoms or fatigue or 
malaise 3 months before their carcinoma is diagnosed [8]. 
The pathogenesis of MAN has yet to be determined; however, a few hypotheses have 
been suggested. A humoral factor produced by the tumor is likely, since there are cases in 
which the skin disorder improved or resolved following treatment of the malignancy [11]. 
Elevated urinary transforming growth factor-α (TGF-α) and increased expression of 
epidermal growth factor (EGF) receptors in lesional skin were noted in a patient with 
acanthosis nigricans and Leser-Trélat sign [11]. A separate case with gastric cancer was 
also shown to express TGF-α and EGF receptors [12]. More recently, a pathogenic role 
has been proposed for a tyrosine kinase receptor expressed in the basal cells of the 
epidermis [13]. However, the specific humoral factor produced by tumors has not yet 
been reported in a separate case of ovarian cancer. 
Early detection of ovarian cancer increases possibilities of successful treatment and 
survival rate. MAN can provide a clue to an early detection of ovarian cancers. Indeed, it 
has often been reported as the first sign of a malignancy that was discovered several 
months later. In the cases previously reported in the literature, acanthosis nigricans in one 
patient and tripe palms in another patient preceded the discovery of endometrial cancer 
by 4 years and 3 years, respectively [6]. Furthermore, the persistence or recurrence of skin 
lesion can be a significant indicator of successful treatment and neoplasm progression [5]. 
MAN tends to be parallel to the course of the cancer, namely, it will spread and worsen 
with progression of the tumor, regress with successful therapy, and recur with recurrence 
and metastases of the tumor [14–16]. 
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Fig. 1. The patient presented with a diffuse velvety thickening and prominent ridges of the palms and 
soles. 
 
 
 
Fig. 2. Well-defined thickened brownish plaques on the axillary area were observed. 
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Fig. 3. A skin biopsy of the hyperkeratotic plaque of the palm showed marked hyperkeratosis and 
acanthosis in the epidermis (HE, 100×). 
 
 
 
Fig. 4. Histopathologic examination of the plaque in the axillae revealed hyperkeratosis, slightly 
irregular acanthosis and prominent dermal papillomatosis (HE, 100×). 
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Fig. 5. CT revealed a 13.6-cm sized cystic and solid mass in the uterus. There were multiple paraaortic 
and retroperitoneal lymph node enlargements. 
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